FDA NDC Directory · JSON-LD · Markdown

REBIF REBIDOSE

NDC 44087-3344 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameINTERFERON BETA-1A
Labeler / ManufacturerEMD Serono, Inc.
Marketing categoryBiologic License Application · App BLA103780
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINTERFERON BETA-1A (44 ug/.5mL)
Marketing started20121221
Package count1

External sources

Source: openFDA. Public-domain (CC0).